
BioNano Genomics Inc (NASDAQ:BNGO) shares are trading sharply lower in Tuesday’s session after the company announced the pricing of a $10 million public offering.
What To Know: The company announced it is offering 5 million shares of its common stock (or equivalents) and accompanying Series Warrants at a combined price of $2.00 per share. The offering includes Series E and short-term Series F warrants, which will be immediately exercisable upon issuance.